•
Mar 31, 2014

EyePoint Pharmaceuticals Q3 2014 Earnings Report

Total Revenue
$2M
Previous year: $513K
+289.9%
EPS
-$0.8
Previous year: -$1.2
-33.3%
Gross Profit
$1.99M
Cash and Equivalents
$18.6M
Total Assets
$26M

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals